The Centers for Medicare & Medicaid Services (CMS) has initiated a pair of coordinated regulatory moves aimed at refining and expanding the delivery of community-based palliative care, a development that healthcare clinicians and policy analysts suggest could fundamentally alter the trajectory of serious-illness management in the United States. Through the Calendar Year (CY) 2027 Home Health Prospective Payment System (HH PPS) proposed rule and the CY 2027 Physician Fee Schedule (PFS) proposed rule, the agency is signaling a shift toward a more integrated, "upstream" approach to care for patients who do not yet meet the strict criteria for hospice but require specialized support for advanced illnesses.
These actions represent a response to long-standing advocacy from the medical community, which has argued that the current Medicare structure forces a binary choice between curative treatment and end-of-life hospice care. By exploring a middle ground—community-based palliative care (CBPC)—CMS is looking to address the gap where patients often suffer from unmanaged symptoms, lack of care coordination, and frequent, avoidable emergency department visits.
The Dual Regulatory Strategy: Clarification vs. Innovation
The two regulatory actions, while coordinated, serve distinct purposes. The first, embedded within the CY 2027 Home Health proposed rule, acts as a clarification of existing authorities. CMS specified that skilled palliative care services are eligible for billing under the current Medicare home health benefit. This move confirms that eligible patients with serious illnesses can receive palliative interventions earlier in their disease course than the traditional six-month terminal prognosis required for hospice.
However, industry experts note that the home health framework is historically a poor fit for the palliative population. Under current regulations, home health eligibility typically requires a patient to be "homebound" and possess a discrete, skilled nursing or therapy need. Furthermore, the benefit is structured around a restorative model—measuring success based on a patient’s improvement or recovery. In contrast, many patients with advanced, progressive illnesses may not be homebound in the strictest legal sense, nor is their clinical trajectory expected to be restorative. Instead, they require symptom stabilization and the maintenance of quality of life as they decline.
The second and more consequential move is found in the CY 2027 Physician Fee Schedule. In this rule, CMS issued a formal Request for Information (RFI) seeking feedback on the creation of a dedicated, standalone community-based palliative care benefit. This potential benefit would exist outside the hospice framework, allowing patients to continue curative or life-prolonging treatments while receiving specialized palliative support. The RFI represents a high-level inquiry into how such a benefit should be designed, who should be eligible, and how it should be reimbursed to ensure sustainability and prevent fraud.
Chronology of Palliative Care Integration
The journey toward a standalone palliative care benefit has been decades in the making. Historically, palliative care was synonymous with hospice, which was established as a Medicare benefit in 1982. However, the requirement that patients waive curative treatment and have a life expectancy of six months or less created a "hospice cliff" that many patients were unwilling or unable to cross until their final days.
In the mid-2010s, the Center for Medicare and Medicaid Innovation (CMMI) launched the Medicare Care Choices Model (MCCM). This pilot program allowed Medicare beneficiaries to receive palliative care services from hospice providers while still pursuing curative treatments. The results of the MCCM were significant: the model showed reduced hospitalizations, improved patient satisfaction, and a smoother transition to hospice when appropriate.
Following the conclusion of MCCM, there was a brief period of stagnation in federal palliative policy. The CY 2027 proposals mark the first major effort to codify these lessons into broader Medicare rules. The timeline for these specific rules saw comments on the home health rule close on August 31, while the physician fee schedule RFI comments concluded on September 14. These deadlines have now passed, leaving the industry in a waiting period as CMS reviews the feedback from physicians, advocacy groups like LeadingAge, and specialized palliative care providers.
Addressing the Clinical Gaps in Serious-Illness Care
The necessity of a community-based model is rooted in the clinical realities of chronic, advanced diseases such as congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), and advanced stage cancers. These conditions are characterized by periods of relative stability punctuated by acute crises.
Currently, without a dedicated palliative benefit, these patients often rely on fragmented primary care or specialist visits. When symptoms like pain, dyspnea, or nausea become unmanageable at home, the default solution is the emergency room. Community-based palliative care is designed to fill this gap through several key interventions:
- Symptom Management: Providing specialized clinical expertise to manage complex pain and non-pain symptoms in the home setting.
- Goals-of-Care Conversations: Facilitating ongoing dialogues about the patient’s values and preferences, ensuring that medical interventions align with what matters most to the individual.
- Medication Reconciliation and Deprescribing: Reducing polypharmacy by removing medications that no longer provide benefit or may cause harmful side effects in the context of a progressive illness.
- Caregiver Support: Addressing the physical and emotional strain on family caregivers, which is often the primary driver of institutionalization or hospital readmission.
The CMS RFI specifically asked whether eligibility for these services should be based on a terminal prognosis—similar to hospice—or if it should instead hinge on a patient’s functional status and the level of caregiver strain. Clinicians have largely advocated for the latter, arguing that functional impairment is a more accurate predictor of the need for palliative support than a specific time-based prognosis.
Data and Economic Implications
The economic argument for community-based palliative care is supported by a growing body of data. According to various health outcomes studies, patients receiving home-based palliative care experience 35% to 50% fewer emergency department visits and hospitalizations compared to those receiving standard care.
Furthermore, a study published in the Journal of Palliative Medicine indicated that community-based programs can save health systems an average of $12,000 per patient in the final months of life by avoiding high-cost, low-value ICU admissions and invasive procedures that do not align with patient goals. By shifting the focus from reactive acute care to proactive home-based management, CMS aims to bend the cost curve of the "highest-cost 5%" of Medicare beneficiaries—those with multiple chronic conditions and functional limitations.
The New Jersey Medicaid Pilot: A National Test Case
While CMS considers federal action, the state of New Jersey has become a vital testing ground for these concepts. On April 1, 2026, New Jersey launched a Medicaid community-based palliative care benefit that many see as a blueprint for the federal government.
The New Jersey model utilizes a per-member-per-month (PMPM) reimbursement structure, which provides an interdisciplinary team—including doctors, nurses, social workers, and chaplains—with a steady stream of funding to manage patients’ needs. Crucially, the New Jersey benefit does not require a terminal prognosis and allows for the continuation of curative treatments.
The success of this pilot will be measured by its ability to reduce avoidable utilization and improve the quality of life for New Jersey’s most vulnerable residents. CMS is expected to monitor the data coming out of this program closely, particularly regarding referential patterns from hospitals and the frequency of home visits required to maintain clinical stability.
Stakeholder Reactions and Challenges
The response from the healthcare sector has been cautiously optimistic. Organizations such as LeadingAge and the National Hospice and Palliative Care Organization (NHPCO) have praised CMS for recognizing the unique needs of the serious-illness population. However, they have also raised concerns regarding the implementation of the home health clarification.
Advocates point out that the home health benefit’s "restorative" focus could lead to "clawbacks" or audits if a palliative patient’s condition naturally declines, as the current metrics for home health success are often tied to physical improvement. There is a strong call for CMS to develop new quality metrics specifically tailored to palliative care, such as "percentage of days spent at home" or "concordance between care received and patient goals."
Furthermore, CMS has expressed concern regarding fraud and abuse. The history of the hospice benefit has been marred by occasional instances of providers enrolling patients who did not meet eligibility criteria to secure long-term payments. To mitigate this, any new community-based benefit will likely require stringent documentation of functional decline and regular re-certification of the need for specialized palliative care.
Future Outlook and Implications for Physicians
The transition toward a standalone community-based palliative care benefit represents a maturation of the U.S. healthcare system’s approach to aging and chronic disease. For physicians, the potential for a new benefit means more tools to support their most complex patients. It offers a pathway to provide "wrap-around" services that a standard 15-minute office visit cannot accommodate.
As CMS moves from the RFI stage toward potential rulemaking in the coming years, the focus will remain on the evidence. The agency’s decision to seek direct physician feedback underscores the clinical nature of these questions. Whether this leads to a permanent Medicare benefit will depend on the ability of current programs, like the one in New Jersey, to prove that interdisciplinary, home-based care can deliver better outcomes at a lower cost.
For now, the clarification in the home health rule provides a temporary, albeit imperfect, bridge. The real transformation, however, lies in the potential for a dedicated benefit that recognizes palliative care not as a precursor to death, but as a vital component of living well with a serious illness. The healthcare industry now awaits the final rules for 2027, which will determine if these "opened doors" lead to a new era of serious-illness care.
